DEA Schedule CIII
Strength
28 mg/.2mL
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458002803
Classification
Brand
Dosage Form
SOLUTION
Route
NASAL
Last Updated
1/29/2026
Active Ingredients
ESKETAMINE HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA211243On Market Since
3/5/2019
Related Drugs
Same classification
No related drugs found.